Chemotherapy appears to be independently associated with reduced pain severity in advanced pancreatic cancer, reinforcing the ...

The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist ...

Although neurological symptoms (motor deficits, sensory impairment) were more frequent in patients with sitting-related ...

Adults who received cryoanalgesia during minimally invasive thoracic surgery experienced higher neuropathic pain scores at ...

A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently ...

Immediate septoplasty is more costly but more clinically effective than medical management for deviated septum. 2. Over a ...

In this cross-sectional study, one-third of federally qualified health centers (FQHCs) in the United States did not provide onsite prenatal care and instead referred pregnant patients to external ...

In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ...

In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase ...

A June 2026 NPR investigation found the commercial gut microbiome market has run far ahead of what the science actually ...

Administration of perioperative intravenous vitamin C for percutaneous renal biopsy may not reduce the rate of bleeding ...